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Animal models of diseaseInﬂammation is a growing area of research in neurodegeneration. In Huntington's disease (HD), a fatal inherited
neurodegenerative disease caused by a CAG-repeat expansion in the gene encoding huntingtin, patients have in-
creased plasma levels of inﬂammatory cytokines and circulating monocytes that are hyper-responsive to im-
mune stimuli. Several mouse models of HD also show elevated plasma levels of inﬂammatory cytokines. To
further determine the degree to which thesemodels recapitulate observations in HD patients, we evaluated var-
ious myeloid cell populations from different HD mouse models to determine whether they are similarly hyper-
responsive, as well as measuring other aspects of myeloid cell function. Myeloid cells from each of the three
mousemodels studied, R6/2,HdhQ150 knock-in and YAC128, showed increased cytokine productionwhen stim-
ulated. However, bone marrow CD11b+ cells did not show the same hyper-responsive phenotype as spleen and
blood cells. Furthermore, macrophages isolated from R6/2 mice show increased levels of phagocytosis, similar to
ﬁndings inHDpatients. Taken together, these results show signiﬁcant promise for thesemousemodels to be used
to study targeting innate immune pathways identiﬁed in human cells, thereby helping to understand the role the
peripheral immune system plays in HD progression.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Huntington's disease (HD) is an autosomal dominant inherited neuro-
degenerative disease caused by a CAG-expansion in exon 1 of the
huntingtin (HTT) gene, resulting in a mutant form of the protein (mHTT)
that contains an elongated polyglutamine tract (The Huntington's
Disease Collaborative Research Group, 1993). It is characterised by
motor, cognitive and neuropsychiatric symptoms, which are associated
with a loss of medium spiny neurons in the striatum and other changes
in the CNS (Vonsattel and DiFiglia, 1998). However, patients are also
affected by peripheral symptoms such as weight loss, muscle wasting
and inﬂammation (van der Burg et al., 2009).
Animal models are a vital tool to research genetic diseases. In HD,
many animal models have been established, including invertebrate
models such as Drosophila melanogaster (Kazemi-Esfarjani and Benzer,erative Disease, UCL Institute of
44 207 676 2180.
om).
. This is an open access article under2000) and Caenorhabditis elegans (Parker et al., 2001), and mammalian
models from rodents (Crook and Houseman, 2011) to primates (Yang
et al., 2008). Invertebrate models have great potential for drug discovery
studies such as therapeutic screens due to their short life-span and cost ef-
ﬁciency (Voisine et al., 2007), but they may not always be useful due to
their relative lack of homology to the human genome. For example, inver-
tebrate immune responses are very different to those in humans, with an
innate immune system that shows distinct differences and the complete
absence of an adaptive immune system (Beck and Habicht, 1996).
A variety of HDmousemodels have been developed. Themostwide-
ly used and best characterised is the R6/2, which ubiquitously expresses
the 5′ end of the human HTT gene carrying only exon 1 with 150 CAG
repeats (Mangiarini et al., 1996). The mice demonstrate a fast and pro-
gressive phenotype with a very early symptomatic onset at 6–8 weeks,
showingmotor symptoms, loss of brain volume and peripheral changes
such as weight loss (Bjorkqvist et al., 2006; Li et al., 2005; Mangiarini
et al., 1996). Moreover, these mice are a model of the mis-splicing of
the HTT gene that occurs to generate an exon 1 HTT protein in all full
length HD mouse models (Sathasivam et al., 2013).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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mHTT have also been developed. The HdhQ150 model was generated
by knocking-in an expanded repeat of 150 CAGs into the mouse Htt
gene (Lin et al., 2001) and develops progressive HD related phenotypes
until end-stage disease at approximately 22 months of age (Woodman
et al., 2007). At late-stage disease, the R6/2 mice (12–14 weeks) are re-
markably comparable toHdhQ150mice (22 months), with bothmodels
exhibiting weight loss, motor abnormalities and widespread mHTT ag-
gregates throughout the brain (Woodman et al., 2007), aggregates in
peripheral tissues (Mofﬁtt et al., 2009), highly comparable transcrip-
tional proﬁles (Kuhn et al., 2007) and a progressively impaired heat
shock response (Labbadia et al., 2011). YAC128 mice are transgenic for
the full-length human HTT gene originally containing 128 CAG repeats
(Slow et al., 2003). They develop progressive motor deﬁcits from the
age of six months, and show selective cortical and striatal atrophy at
nine months (Van Raamsdonk et al., 2005).
HD patients have elevated plasma levels of inﬂammatory cytokines
and chemokines (Bjorkqvist et al., 2008; Wild et al., 2011), and their
monocytes are hyper-reactive following lipopolysaccharides (LPS)
stimulation in vitro (Träger et al., 2014). In mice, the R6/2, HdhQ150
and YAC128 models each have similarly elevated plasma levels of in-
ﬂammatory cytokines (Bjorkqvist et al., 2008). Myeloid cells from
both R6/2 and BACHDmice have also been shown tomigrate abnormal-
ly (Kwan et al., 2012b), demonstrating that they are affected by mHTT
expression. Here, myeloid cells from different HD mouse models were
evaluated to assess whether they are similarly hyper-responsive, like
HD patient cells. We analysed cytokine production and other key im-
mune cell functions in cultured cells, comparing several commonly-
studied myeloid cell populations from blood, spleen and bone marrow.Materials and methods
Animals
Mice from colonies at King's College London (KCL)were used for the
cytokine proﬁling, phagocytosis assays and FACS analyses. R6/2 mice
(Mangiarini et al., 1996) were bred by backcrossing hemizygous males
to (CBA × C57BL/6)-F1 females (B6CBAF1/OlaHsd; Harlan, UK).
HdhQ150 homozygous mice on a (CBA × C57BL/6) F1 background
(Hdh150Q/150Q) were obtained by inter-crossing HdhQ150 heterozygous
CBA/Ca and C57BL/6J congenic lines as described previously
(Woodman et al., 2007). For the differentiation and cell adhesion assays,
R6/2 mice from a colony at Lund University were used (Jackson Labora-
tories, USA), obtained by crossing heterozygous (C57BL/6) males with
(C57BL/6) females. Experiments using YAC128 mice were undertaken
at the University of British Columbia, Vancouver. All animals had unlim-
ited access to food andwater,were subject to a 12-h light/dark cycle and
housing conditions and environmental enrichment were as previously
described (Hockly et al., 2003).
At KCL, R6/2 andHdhQ150micewere genotyped by PCR using geno-
mic DNA isolated from an ear-punch and theHtt CAG repeat length was
measured as previously described (Sathasivamet al., 2010). The CAG re-
peat size for the KCL R6/2 mice was 209.3 ± 8.5 and for the HdhQ150
mice it was 163.3 ± 2.8. At Lund University, tail tips were taken at
4 weeks of age and genotyped by PCR at Laragen (Laragen, USA). The
CAG repeat length size for the Lund R6/2 mice was 240–252 repeats.
The YAC128 mice had a CAG repeat length of 120 ± 0.343.
At KCL, all experimental procedures were approved by the Local
Ethics Committee and performed under a project licence issued by the
UK Home Ofﬁce. Experimental procedures at Lund University were car-
ried out in strict accordance with Swedish legislation and approved by
the Animal Ethics Committee in Lund and Malmö, Sweden, and at the
University of British Columbia they were performed in accordance
with protocols approved by the University of British Columbia Commit-
tee on Animal Care and the Canadian Council on Animal Care.Isolation of primary murine cells
Blood monocytes
Blood was obtained by cardiac puncture, collected into EDTA coated
tubes (BD Vacutainer), and 1 ml red blood cell lysis buffer (ammonium
chloride buffer; eBioscience) was added per 1 ml of blood. The samples
were then incubated for 5min at room temperature. Following centrifu-
gation at 300 ×g for 5min, the lysis step was repeated twice. Cells were
then resuspended in 270 μl MACS buffer (PBS including 1% bovine
serum albumin (BSA) and 2 mM EDTA) and 30 μl anti-mouse CD11b
magnetic beads. After 15 min incubation in the fridge, the samples
were washed in MACS buffer (300 ×g for 5 min), resuspended in
500 μl MACS buffer and loaded on pre-wetted MACS columns placed
in the magnet. After allowing the cell suspension to ﬂow through by
gravity, the columns were washed three times with 1 ml MACS buffer.
Labelled CD11b+ monocytes were eluted by removing the columns
from the magnetic ﬁeld.
Bone marrow
Mice were sacriﬁced by neck dislocation or by rising concentration
of CO2. Femur and tibia were dissected at the hip joint and any remain-
ing muscle tissue was carefully removed. The bones were placed in a
petri dish ﬁlled with cold RPMI-1640 media and cut at the joints. Bone
marrowwasﬂushed out by rinsing the shaft withmedia using a 5ml sy-
ringe and 26 gauge needle. Lumps of cells were disaggregated by pipet-
ting up and down several times before the cells were passed through a
70 μmnylon cell strainer. After washingwith RPMI-1640media (centri-
fugation at 300 ×g for 5 min) cells were counted using a Neubauer
counting chamber. The cell suspension was labelled with 10 μl anti-
mouse CD11b magnetic beads and 90 μl MACS buffer per 1 × 107 cells,
and sorted as described above. When seeded in culture the isolated
CD11b positive cell population resembled an early monocyte popula-
tion, which could then be differentiated into bone marrow-derived
macrophages. For the differentiation, sorted bone marrow cells were
cultured in R10 media (RPMI-1640 supplemented with 10% FBS, 2 mM
L-glutamine, 50 units/ml penicillin and 50 mg/ml streptomycin supple-
mented with 20 ng/ml recombinant murine M-CSF). After 3 days cells
were providedwith freshmedia and growth factor. The cells resembled
a macrophage phenotype from day 6.
Spleen
Spleens were dissected from the mice and stored in RPMI-1640
media until the preparation was started. To obtain a single cell suspen-
sion, spleens were cut into pieces and digested using 2 ml digestion
buffer (RPMI-1640 media including 10% FBS, 15 mMHEPES, 0.5% colla-
genase type 4 (C1889; Sigma-Aldrich)). After 30 min incubation at
room temperature the remaining spleen pieces were ﬁltered through
a 70 μm nylon cell strainer (BD Falcon). Afterwards, the splenocytes
were centrifuged (300 ×g for 5 min) and the pellet was incubated
with 1 ml red blood cell lysis buffer for 5 min at room temperature.
Cells were then counted using a Neubauer counting chamber and isolat-
ed using 10 μl anti-mouse CD11bmagnetic beads and 90 μl MACS buffer
per 1 × 107 cells as described for blood monocytes.
Peritoneal macrophages
In order to prevent bleeding into the abdominal cavity, mice were
killed using a rising concentration of CO2. Fur covering the peritoneum
was carefully removed and 5ml of ice-cold, serum free RPMI1640medi-
um was injected into the abdominal cavity using a 26 gauge needle.
After massaging the mouse abdomen for 1–2 min, cells were recovered
through a small incision using a sterile plastic Pasteur pipette and put on
ice as quickly as possible. The centrifuged (5min at 300×g) cell suspen-
sionwas incubatedwith 1ml red blood cell lysis for 5min at room tem-
perature. Afterwards, the cells were washed with PBS (centrifuged at
300 ×g for 5 min). The resultant cell suspension contained macro-
phages as well as neutrophil, so cultures were enriched for
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ing and washing the cells after 2 h in a culture.
Cytokine proﬁling of R6/2 and HdhQ150mice
Blood monocytes isolated from HdhQ150 mice were seeded at
100,000 cells into 96-well plates in 100 μl R10 media. Due to low yields
from R6/2 mice, cells were pooled according to genotype and multiple
wells were seeded at 100,000 cells into 96-well plates in 100 μl R10
media. Splenic and bone marrow monocytes were seeded in 24-well
plates at a density of 500,000 cells per well. All cultures were primed
with 10 ng/ml murine IFNγ and stimulated with 2 μg/ml LPS. After
24 h, supernatants were collected for analysis of cytokine levels using
multiplex ELISAs (mouse pro-inﬂammatory 7-Plex tissue culture kit
measuring IFNγ, IL-1β, IL-10, IL-12p70, IL-6, mKC, TNFα) according to
the manufacturer's instructions (Meso Scale Discovery). Cells were
lysed in RIPA buffer (25 mM Tris–HCl pH 7.6, 150 mM NaCl, 1% NP-40,
1% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS)) for pro-
tein measurement by BCA assay (Thermo Scientiﬁc).
Cytokine proﬁling of YAC128 mice
Peritoneal macrophage isolated from wild-type and YAC128 mice
were seeded in 24-well plates at a density of 500,000 cells per well.
Bone marrow-derived macrophages were used for stimulation experi-
ments after differentiation in 6-well plates at 3 × 106 cells per well. All
cultures were primed with 12.5 ng/ml murine IFNγ and stimulated
with 100 ng/ml control standard endotoxin (CSE). After 24 h, superna-
tants were collected for analysis of IL-6 levels by ELISA according to
manufacturer's instructions (e-Bioscience). Cells were lysed in RIPA
buffer (25 mM Tris–HCl pH7.6, 150 mM NaCl, 1%NP-40, 1% sodium
deoxycholate, 0.1% sodium dodecyl sulphate (SDS)) for protein mea-
surement by BCA assay (Thermo Scientiﬁc).
Collection and classiﬁcation of human samples
All human experiments were performed in accordance with the
Declaration of Helsinki and approved by the University College
London (UCL)/UCL Hospitals Joint Research Ethics Committee. All sub-
jects provided informed written consent. Blood samples were obtained
from control subjects and genetically-diagnosed HD patients. Subjects
with inﬂammatory or infective conditions were excluded.
Isolation of human monocytes and macrophages
CD14+ monocytes were isolated from whole blood, as previously
described (Bjorkqvist et al., 2008), and differentiated into macrophages
by supplementing the RPMI culture medium containing 10% FBS, 2 mM
L-glutamine, 50 U/ml penicillin and 50 μg/ml streptomycin (Invitrogen)
with 20 ng/ml GM-CSF for 6 days.
Flow cytometry
Up to 1× 106 cells perwell were transferred into a round bottom96-
well plate and centrifuged at 300 ×g for 5 min. If necessary the cells
were ﬁxed in 4% paraformaldehyde (in PBS). The cells were then gently
resuspended in 50 μl of antibody (Table S1) suitably diluted in FACS
buffer (PBS with 1% FBS and 0.02% sodium azide). Cells were stained,
in the dark, for at least 30 min on a shaker at 4 °C. Afterwards the cells
were washed once in 200 μl FACS buffer (centrifuged at 300 ×g,
5 min), resuspended in 200 ml FACS buffer, transferred to FACS tubes
and analysed using either a special-order BD Bioscience FACScan
cytometer (Cytek) with CellQuest Pro (BD Bioscience) and Rainbow
(Cytek) software, or a MACSQuant ﬂow cytometer (Miltenyi Biotech)
with MACSQuantify software. Data analysis was performed usingFlowJo7.2.5 (Tree Star) software. Non-stained and single-colour stained
cell controls were always performed.Cell function assays
Phagocytosis assay
Macrophages were stimulated with 2 μg/ml LPS in R10 media over-
night. One hour before the assay, macrophages were washed three
times with PBS and serum-free RPMI-1640 was added to the cells.
Carboxylate-modiﬁed ﬂuorescent yellow-green latex beads (Sigma Al-
drich) were added to the cells at a 10:1 ratio and were incubated at
37 °C for 1 h. Cells were thenwashedwith cold PBS twice and incubated
with PBS containing 10 nMEDTA for 10min on ice before the cells were
detached from the culture wells by trituration. The cells were then ﬁxed
using 3.7% paraformaldehyde for 20 min at room temperature, follow-
ing which the cells were washed and stained with macrophage-
lineage speciﬁc cell surface markers for analysis by ﬂow cytometry.Cell adhesion assay
Peritoneal macrophages were seeded in 24-well plates and left to
adhere to the plastic for 2 h. Adhered cells were removed and counted
using a Neubauer counting chamber.Differentiation assay
CD11b+ cells isolated from bone marrow were differentiated using
20 ng/ml recombinant murine M-CSF. After 4 days, undifferentiated
monocyteswerewashedoff before differentiated adheredmacrophages
were lifted of the plastic and counted using a Neubauer counting
chamber.Migration assay
One hundred thousand macrophages were seeded into 8 μm
transwell inserts, which were placed into wells ﬁlled with RPMI-1640
media containing 1% FBS, 2 mM L-glutamine, 50 units/ml penicillin
and 50 mg/ml streptomycin supplemented with 50 ng/ml CCL2 (MCP-
1). The cells were incubated for either 90 min or 16 h, after which the
inserts were removed from the wells. Cells on the upper side of the in-
sert membrane were gently removed using cotton buds, whilst the
cells on the lower side were ﬁxed in ethanol and stained with 1 mg/
ml crystal violet. The ﬁxed, stained cells were counted in multiple ﬁelds
of view using ImageJ software. Pictures were taken using a light micro-
scope (Nikon Eclipse TS100, Objective 20×) with an attached digital
camera (Nikon DS-Fi1) and NIS-Elements F 3.00 software.TR-FRET
The experimentwas performed aspreviously described (Weiss et al.,
2012). In brief, cells were lysed in 100 μl PBS containing 1% Triton X-100
and a protease inhibitor cocktail (Roche) per 1 × 106 cells and 5 μl cell
lysate was transferred into low-volume wells of white 384-microtitre
plates (Greiner). A total of 1 ml detection buffer (50 mM NaH2PO4,
400 mM NaF, 0.1% BSA, and 0.05% Tween, plus antibody mix) was
added, with the ﬁnal antibody amount per well for solublemHTT detec-
tion being 0.25 ng 2B7-Tb plus 20 ng MW1-D2. Plates were rotated at
1000 ×g for 30 s and incubated for 1 h. TR-FRET readoutwas performed
with an EnVision 102 Reader (PerkinElmer). After the excitation of the
donor ﬂuorophore Tb (CisBio) at 320 nm and a time delay of 100 ms,
the resulting Tb and acceptor D2 (CisBio) emission signals were read
at 620 nm and 665. Ratios of 665/620 nm signals corresponded to
mutant HTT levels. HTT protein levels are shown as a percentage of
the signal intensity over lysis buffer background signal after normalisa-
tion to total protein levels (4F). All assays were carried out blinded to
the subject group.
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Datawere analysed using unpaired two-tailed Student's t-tests, unless
otherwise stated. All error bars represent standard error of the mean.
Results
Cytokine proﬁling of myeloid cells in R6/2 mice
To determine whether monocytes fromHDmousemodels are hyper-
reactive like those from HD patient blood (Träger et al., 2014), CD11b+
cells from 12-week old R6/2 mice were isolated using magnetic cell
sorting and seeded in culture, then primed with IFNγ and stimulated
with LPS for 24 h. Analysis of culture supernatants using a multiplex
ELISA platform showed an increase in IL-6 and TNFα levels, but not IL-B
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and IL-10were unchanged (Figs. 1B and S1B). R6/2 bonemarrowmyeloid
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Next, we wanted to see how myeloid cells from mouse models ex-
pressing the full-length mHTT protein compared with models such as
R6/2 that express an exon 1 fragment of the mutant gene. The knock-
in HdhQ150 model expresses 150 CAG repeats in the endogenous
mouse Htt gene (Lin et al., 2001). Therefore, we analysed the respon-
siveness of the myeloid cells from these mice at an age of 22 months
(comparable to a R6/2 mouse at 12 weeks).
CulturedHdhQ150 bloodmonocytes primedwith IFNγ and stimulat-
ed with LPS for 24 h demonstrated a signiﬁcant increase in IL-1β, TNFα
and IL-12 production when compared with those from wild-type mice
(Figs. 2A and S2A). IL-6 levelswere also elevated, but thiswas not statis-
tically signiﬁcant (Fig. 2A). Cultured spleenmyeloid cells fromHdhQ150
mice stimulated as above demonstrated signiﬁcantly elevated levels of
IL-6 and TNFα, and a slight increase in IL-1β and IL-10, compared with
wild-type cells (Figs. 2B and S2B). In contrast, cultured HdhQ150 boneA
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Fig. 2. Altered cytokine production by myeloid cells from HdhQ150mice. (A) Blood, (B) spleen
typemice using anti-CD11bmagnetic beads and seeded in culture for stimulation with IFNγ an
cells produced similar levels of cytokine compared with wild-type, both blood and spleenmyel
mean concentrations corrected to protein content ±SEM. Unpaired two-tailed Student's t-testmarrowmyeloid cells did not show any differences in cytokine produc-
tion when stimulated, compared to wild-type cells (Figs. 2C and S2C).
This suggests that bone marrow myeloid cells behave differently to
other more mature peripheral monocytes and macrophages.
Another full-length mHTT-expressing HD mouse model is the
YAC128 model expressing the entire human HD gene (Slow et al.,
2003). From this model, bone marrow-derived macrophages from
three month old mice were cultured, primed with IFNγ and stimulated
with CSE for 24 h. Supernatants from these cultures showed no differ-
ence in IL-6 levels when comparing YAC128 and wild-type cells
(Fig. 3). This strengthens further the evidence that bone marrow-
derived myeloid cells do not show the same mHTT-dependent differ-
ences as other, more mature myeloid cell populations, and do not
mimic the hyper-responsive phenotype observed in human HD blood-
derived monocytes. In contrast, cultured YAC128 peritoneal macro-
phages stimulated with CSE showed a signiﬁcant increase in IL-6 pro-
duction compared with wild-type cells (Fig. 3).p=0.0464 TNF-α
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Fig. 3.Altered cytokine production bymacrophages fromYAC128mice. Peritoneal macro-
phages obtained via peritoneal lavagewere stimulatedwith CSE for 24 h before IL-6 levels
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cells compared with wild-type controls. Graphs show mean concentrations corrected to
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Mutant HTT levels measured in primary human immune cells corre-
late with markers of disease progression such as disease stage, disease
burden score and caudate atrophy (Weiss et al., 2012). Therefore, the
observation that mouse myeloid cells isolated from bone marrow ap-
pear to be normal compared with more mature myeloid cells isolated
from other peripheral tissues may be due to relative differences in the
levels of mHTT expression.
However, themeasurement ofmHTT levels showed that CD11b+ cells
isolated from the bone marrow and spleen of 12-week old R6/2 mice are
not signiﬁcantly different (Fig. 4), suggesting that this is not the explana-
tion for why bone marrowmyeloid cells from HDmouse models are not
hyper-responsive. Interestingly, whilst mHTT levels in whole spleen are
similar to those in cells that have been sorted by CD11b+, unsortedCD11b+
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Fig. 4.Mutant HTT levels in R6/2 spleen and bonemarrow. Single cell suspensions obtain-
ed from bone marrow, spleen as well as magnetically sorted spleen and bone marrow
CD11b+ cells from 12-week old R6/2 and wild-type mice (n = 8), were lysed and used
to assess mHTT levels. TR-FRET measures demonstrated that mHTT levels are similar in
CD11b+ immune cells isolated from spleen and bone morrow. No mHTT was detected
in controlmice (n=3). Data shown as percentage of the signal intensities over lysis buffer
background signal after normalisation to total protein levels.bonemarrow that contains a large number of stem cells shows increased
levels of mHTT expression compared to sorted cells (Fig. 4).
CD11b+ cell populations in bone marrow and spleen of R6/2 mice
Differences in cytokineproductionbymyeloid cells fromHDandwild-
type mice could be accounted for by relative differences in the propor-
tions of different CD11b+ cell populations in the samples. Nearly all cul-
tured CD11b+ cells from blood are monocytes, but in the spleen and
bone marrow the CD11b+ population also comprises, for example, mac-
rophages, dendritic cells and granulocytes. To test this in R6/2 mice,
CD11b+ cells were isolated from the spleen and bone marrow of trans-
genic andwild-typemice, as done previously, and stained forﬂow cytom-
etry quantiﬁcation of different CD11b+ populations (Fig. S3). In the
spleen, most CD11b+ cells were monocytes, macrophages or lymphoid-
derived dendritic cells (DCs), whereas in the bone marrow there were
many more granulocytes (Table S2). Sorted cells from both tissues
contained less than 1.5% contaminating B cells and T cells. There was no
evidence of any signiﬁcant differences between R6/2 and wild-type
mice in their spleen and bone marrow CD11b+ populations (Table S2).
R6/2 mouse spleens contain normal proportions of immune cells
We also analysed the proportions of different immune cell subsets
within the whole cell population of spleens from 12-week old R6/2
mice. Single cell suspensions prepared from digested spleens were
stainedwith anti-CD3, anti-CD19 and anti-CD11b antibodies asmarkers
for T cells, B cells andmyeloid cells, respectively (Fig. 5A). Nodifferences
in the proportion of these immune cell populations were found in R6/2
as compared with wild-type spleens (Fig. 5B). Following this, spleen
cells were stained with anti-CD3, anti-CD4 and anti-CD8 antibodies to
investigate the abundance of CD4+ Thelper cells and CD8+ cytotoxic T
cells in the spleens of R6/2 mice. However, no differences in T cell sub-
sets were detected in R6/2 spleens when compared with those from
wild-type mice (Fig. S4). We also examined myeloid cell subsets, in
which spleen cells were stained with anti-F4/80 antibody as a macro-
phage marker and a combination of anti-CD11c, anti-B220 and anti-
CD11b antibodies to distinguish between CD11c+ B220+ plasmacytoid
DCs, CD11c+ B220− CD11b− lymphoid-derived DCs and CD11c+
B220− CD11b+ myeloid-derived DCs. Again, no differences in macro-
phage and DC subsets were detectable in R6/2 compared with wild-
type spleens (Fig. S5).
Next, we examined CD11b+ spleen cells more speciﬁcally, using
MHC class II expression levels to categorise the myeloid cells as being
in a resting or activated state (Fig. 6A). Comparing the percentage of
resting (CD11b+,MHCIIlow) and activated (CD11b+,MHCIIhigh)myeloid
cells in spleens from8-week old R6/2mice did not showa difference be-
tween R6/2 and wild-type mice (Fig. 6B), whereas the spleens from
12 week-old animals contained signiﬁcantly fewer activated myeloid
cells and a signiﬁcantly higher percentage of resting monocytes
(Fig. 6C). This may reﬂect an effect of disease progression as R6/2 mice
become symptomatic and closer to end-stage disease at 12 weeks. The
altered ratio of resting versus activated myeloid cells may explain the
increased IL-1β levels observed in R6/2 spleens.
Functional analysis of monocytes and macrophages in R6/2 mice
Phagocytosis is a key function of macrophages and a signiﬁcant ele-
vation in phagocytosis was observed in LPS-stimulated blood-derived
HD patient macrophages comparedwith control cells in a ﬂow cytome-
try based assay (Fig. 7B). To see whether R6/2 mice demonstrate a sim-
ilar phenotype, bone marrow-derived and peritoneal macrophages
were incubated with green ﬂuorescent latex beads and the percentage
of cells phagocytosing beads were analysed by ﬂow cytometry. LPS-
stimulated bone marrow-derived macrophages from 12-week old R6/
2 mice did not demonstrate a difference in phagocytosis levels
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394 U. Träger et al. / Neurobiology of Disease 73 (2015) 388–398comparedwithwild-typemice (Fig. 7C). Peritonealmacrophages isolat-
ed from R6/2 mice, however, showed a small elevation in the percent-
age of phagocytosing cells upon LPS stimulation, similar to the results
in HD patients (Fig. 7D).
Counting the number of differentiated, adhered bone marrow-
derived macrophages four days after seeding showed no difference in
R6/2 compared with wild-type cells (Fig. 8A). In addition, adhesion of
peritoneal macrophages appeared to be normal in R6/2 mice, as the
same number of R6/2 andwild-typemacrophages adhered to the tissue
culture plastic 2 h after seeding (Fig. 8B).
HD patients demonstrate a striking defect in monocyte and macro-
phage migration towards the chemoattractant MCP-1 in in vitro assays
(Kwan et al., 2012b). Furthermore, murine microglia and peritoneal
macrophages have been shown to migrate abnormally in vivo (Kwan
et al., 2012b). Using the same assay used to assess human HD cells
ex vivo, R6/2 mice peritoneal macrophages were seeded on to
transwells and the number of cells migrating towards MCP-1 was
counted by their location in the lower chamber of the transwell system.
Interestingly, peritoneal macrophages from R6/2 and wild-type mice
showed similar levels of migration, both under basal conditions and to-
wards MCP-1 after either 90 min or 16 h (Fig. 8C).
Discussion
It has been shown previously that various HD mouse models have
increased plasma cytokine levels, including R6/2, HdhQ150 and
YAC128 mouse models (Bjorkqvist et al., 2008). This corresponds to
the increased plasma cytokine levels observed in human HD patients
(Bjorkqvist et al., 2008). In this study, we show that blood CD11b+
cells isolated fromR6/2 andHdhQ150 are hyper-reactive upon LPS stim-
ulation in vitro, replicating the phenotype observed in human cells.
Analysing the cytokine proﬁle in the YAC128 mice, peritonealmacrophages were found to produce high levels of IL-6 upon CSE stim-
ulation. Taken together, all three mouse models recapitulate changed
cytokine proﬁles established in HD patients and therefore they could
be used to model the immune phenotype.
However, the origin of themurinemyeloid cell is important, demon-
strated by a lack of phenotype looking at R6/2, HdhQ150 and YAC128
bone marrow cells. Neither CD11b+ bone marrow myeloid cells nor
macrophages derived from bone marrow cells exhibit increased pro-
inﬂammatory cytokine production or phagocytosis. We did not see a
difference in mHTT levels in R6/2 CD11b+ bone marrow compared
with mature myeloid cell populations in the spleen, suggesting that
mHTT levels are not the reason for the lack of phenotype in the bone
marrow. The evidence for a lack of hyper-reactivity in the bonemarrow
myeloid cells is interesting, particularly in light of a recent paper de-
scribing how bone marrow transplants, when given from HD donor to
HD recipient mice, can improve certain aspects of HD pathology, such
as behavioural changes (Kwan et al., 2012a). Bonemarrow transplanta-
tion from both wild-type and BACHD mice into irradiated BACHDmice
improved the outcome of the balance beam and open ﬁeld activity task.
Whilst it remains to be shown how the transplants confer their beneﬁts,
our ﬁnding further indicates phenotypic differences between bonemar-
row and blood myeloid cells that perhaps reﬂect underlying develop-
mental differences between the two populations.
Looking at cytokine production by CD11b+ myeloid cells isolated
from the spleen, HdhQ150mice demonstrated elevated IL-6, IL-1β and
TNFα levels similar to the changes seen from HdhQ150 blood mono-
cytes. The same cells fromR6/2mice, however, only showed an increase
in IL-1β, whilst IL-6 and TNFα levels were unchanged. In contrast to
blood, CD11b+ cells from the spleen comprise a cell suspension that in-
cludes macrophages and DCs as well as the desired monocytes. When
testing whether a shift in the percentage of these different cell types
within the spleen accounts for the rise in IL-1β levels in R6/2 compared
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395U. Träger et al. / Neurobiology of Disease 73 (2015) 388–398with control cells, no differences in the monocyte, macrophage and DC
populationswere detected. However, when looking at the levels of acti-
vation in splenic monocytes usingMHC II expression levels as amarker,
signiﬁcantlymore resting and fewer activatedmonocyteswere found in
R6/2 mice at 12 weeks of age. It might be therefore, that this difference
in the isolated population from the spleen and not a cell-intrinsic hyper-
reactivity of the cells accounts for the difference in IL-1β levels detected
in R6/2 spleen. This means that splenic cells from R6/2micemay not be
a good model for the peripheral myeloid cell function in HD.
Looking at other cellular functions, phagocytosis in peritoneal mac-
rophages from R6/2 mice was increased upon LPS stimulation, resem-
bling the human phenotype. However, R6/2 peritoneal macrophages
did not demonstrate any migration defect in this study. In a different
study, R6/2 mice demonstrate decreased numbers of inﬁltrating perito-
neal macrophages after inducing peritonitis with thioglycolate, when
compared with wild-type mice (Kwan et al., 2012b). Although our
ex vivo experiments did not show the same trend, it is important to
note that the two experiments are not looking at the same aspect ofmigration. In our in vitro migration assay, the ability of peritoneal mac-
rophages to migrate through a membrane towards one chemokine was
tested, whilst an induced peritonitis is not only looking at macrophage
migration, but also monocyte inﬁltration from the blood stream into
the peritoneum. This process requires migration through epithelium
and cell–cell interactions (Imhof and Aurrand-Lions, 2004), which
might be affected in HD and is not modelled in the in vitro assay used
here. Furthermore, the in vivo peritonitis experiment showed that R6/
2 mice have decreased inﬁltration of monocytes and macrophages
into the peritoneum, but inﬁltration did still occur (Kwan et al.,
2012b). It may be an unintended consequence of isolating a pure popu-
lation of peritoneal macrophages that more functional cells were isolat-
ed, which despite a possible defect managed to migrate into the
peritoneum in the ﬁrst place.
Both fragment R6/2 and full-length (YAC128 and knock-in
HdhQ150) HD models recapitulate many speciﬁc aspects of the human
disease, and could be considered for future studies investigating the im-
mune dysfunction in HD and/or targeting it for therapeutics. The use of
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396 U. Träger et al. / Neurobiology of Disease 73 (2015) 388–398mouse models is especially interesting as it allows us to not only study
the peripheral immune system, but also the immune cells within the
CNS. Thiswill help determinewhether peripheralmyeloid cells can pro-
vide insights into the function of microglia that in humans are
inaccessible.
Deciding which tissue is the best for isolation of HD myeloid cells is
difﬁcult. Both R6/2 and HdhQ150 blood monocytes mimic the human
monocyte phenotype well and are good models for the human disease,
as these are the same cells that the human disease has been studied in.
Unfortunately, especially when isolated from 12week old symptomatic
R6/2mice, only around 100,000 to 300,000monocytes can be recovered
from one mouse. Large animal numbers are therefore required for any
experiment. The use of alternative sources for monocytes and macro-
phages such as bone marrow and spleen demonstrated caveats. The
bone marrow myeloid cells and bone marrow-derived macrophages
did not showdifferences in cytokine production and phagocytosis, lead-
ing to the conclusion that immature bone marrow cells are not a good
model to assess monocyte cell function in HD. Splenic myeloid cells
from the R6/2 and HdhQ150mouse models, on the other hand, respond
in a hyper-reactive manner to LPS, but due to their diverse composition
(CD11b+ cells isolated from spleen can be monocytes, macrophages or
DCs), this does not resemble studies on human blood cells that are 100%
monocytes. As ﬂow cytometry showed that the abundance of the differ-
ent cell types does not differ between wild-type and R6/2, spleen cells
may still be used to compare the genotypes, but conclusions as to
which cell type is responsible for differences in phenotypewould be dif-
ﬁcult to draw.Having demonstrated the dysfunction of the immune system in HD
mouse models in the form of increased plasma cytokine levels
(Bjorkqvist et al., 2008) and cytokine production by blood monocytes
in vitro, such models can now be used to target molecules in immune
pathways that have been identiﬁed in human cells. This will further
our understanding of the role of the peripheral immune system in HD
progression, and help identify and test putative targets for therapeutic
intervention.
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